US NATIONAL CANCER INSTITUTE: Scientists are making progress towards finding a life-extending treatment option for men with metastatic castration-resistant prostate cancer. READ MORE>
Posts Tagged ‘US NATIONAL CANCER INSTITUTE’
Prostate cancer cells in mice turn anti-tumour T-cells into cells that suppress immune system
Posted in Immunotherapy, PROSTATE CANCER, PROSTATE RESEARCH, tagged anti-tumour T-cells, cancer research, immune cells, immune responses, immune system, immune-based therapies, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate treatment, suppressive functions, tumor-specific CD8+ T cells, URO TODAY, US NATIONAL CANCER INSTITUTE on October 9, 2009| Leave a Comment »
URO TODAY: Researchers have discovered that prostate tumours in mice can cause immune cells known as CD8+ T cells to change to cells that suppress immune responses. READ MORE>
This finding, by researchers at the US National Cancer Institute, has important implications for the design of immune-based therapies for cancer.
Future work by this team will focus on defining the mechanisms by which gain their suppressive functions.
“This will enhance our ability to generate more effective anti-tumor T cell responses in mice, which then might be translated to human.”
PROSTATE VACCINES: Treatment that boosts immune system may help fight cancer
Posted in New prostate drugs, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, Vaccines, tagged American Society of Clinical Oncology (ASCO) Annual Meeting, cancer research, clinical trials, immune system, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Treatment vaccines, US NATIONAL CANCER INSTITUTE on June 5, 2009| Leave a Comment »
JUNE 5: US NATIONAL CANCER INSTITUTE: Treatment vaccines that boost the immune system’s response to tumours may have important clinical benefits for patients with various types of cancer, according to results from several clinical trials presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando. READ MORE>